Skip to content
2000
image of Current Role of the Zebrafish Experimental Model in Pharmacological Evaluations of Drugs: Current and Future Perspectives

Abstract

Introduction

The zebrafish (), which lives in tropical freshwater, is thought to be one of the best animal models for studying drugs and their effects. This model is unique for its fast growth, clear embryos, genetic similarity to humans, and low cost for experiments. Literature-based data were gathered and shared so that future researchers in the field of pharmacology could get an idea of what kind of work could be done.

Methods

Journal sources like Scopus, Springer, MDPI, and PubMed were used. Seventy-four research papers from 2000 to 2025 were reviewed, but some from before 2020 were added because they were more scientifically sound. Articles about fish that aren't zebrafish were left out.

Results

In order to perform preclinical investigations of several ailments, including diabetes, cancer, cardiovascular disease, and neurological disorders, researchers are using zebrafish as an animal model. The reason behind its use is its similar genetic pattern, similar physiology, rapid development, and optical transparency.

Discussion

Researchers have found heart-healthy phospholipids, antitumor peptides, and anti-diabetic chemicals in zebrafish models, which makes them a great way to study human pathophysiology. studies using zebrafish are also easy to expand and cost-effective.

Conclusion

The emerging zebrafish model is indispensable for translational investigation. This model works as a bridge connecting in vitro assays to mammalian models. The present article is an attempt to showcase the current perspective on the pharmacological model in view of drug discovery involving zebrafish.

© 2025 Bentham Science publishers
Loading

Article metrics loading...

/content/journals/cpd/10.2174/0113816128396857250917224145
2025-09-22
2026-03-02

  • From This Site

    /content/journals/cpd/10.2174/0113816128396857250917224145
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Parichy D.M. Advancing biology through a deeper understanding of zebrafish ecology and evolution. eLife 2015 4 e05635 10.7554/eLife.05635 25807087
    [Google Scholar]
  2. Spence R. Gerlach G. Lawrence C. Smith C. The behaviour and ecology of the zebrafish, Danio rerio. Biol. Rev. Camb. Philos. Soc. 2008 83 1 13 34 10.1111/j.1469‑185X.2007.00030.x 18093234
    [Google Scholar]
  3. Lieschke G.J. Currie P.D. Animal models of human disease: Zebrafish swim into view. Nat. Rev. Genet. 2007 8 5 353 367 10.1038/nrg2091 17440532
    [Google Scholar]
  4. Kalueff A.V. Stewart A.M. Gerlai R. Zebrafish as an emerging model for studying complex brain disorders. Trends Pharmacol. Sci. 2014 35 2 63 75 10.1016/j.tips.2013.12.002 24412421
    [Google Scholar]
  5. Howe K. Clark M.D. Torroja C.F. The zebrafish reference genome sequence and its relationship to the human genome. Nature 2013 496 7446 498 503 10.1038/nature12111 23594743
    [Google Scholar]
  6. Spitsbergen J.M. Kent M.L. The state of the art of the zebrafish model for toxicology and toxicologic pathology research--advantages and current limitations. Toxicol. Pathol. 2003 31 1 Suppl. 62 87 10.1080/01926230390174959 12597434
    [Google Scholar]
  7. Patton E.E. Zon L.I. The art and design of genetic screens: Zebrafish. Nat. Rev. Genet. 2001 2 12 956 966 10.1038/35103567 11733748
    [Google Scholar]
  8. White R.M. Sessa A. Burke C. Transparent adult zebrafish as a tool for in vivo transplantation analysis. Cell Stem Cell 2008 2 2 183 189 10.1016/j.stem.2007.11.002 18371439
    [Google Scholar]
  9. Schier A.F. Genetics of neural development in zebrafish. Curr. Opin. Neurobiol. 1997 7 1 119 126 10.1016/S0959‑4388(97)80129‑8 9039801
    [Google Scholar]
  10. Kimmel C.B. Ballard W.W. Kimmel S.R. Ullmann B. Schilling T.F. Stages of embryonic development of the zebrafish. Dev. Dyn. 1995 203 3 253 310 10.1002/aja.1002030302 8589427
    [Google Scholar]
  11. Hisaoka K.K. Battle H.I. The normal developmental stages of the zebrafish, brachydanio rerio (hamilton‐buchanan). J. Morphol. 1958 102 2 311 327 10.1002/jmor.1051020205
    [Google Scholar]
  12. Parichy D.M. Elizondo M.R. Mills M.G. Gordon T.N. Engeszer R.E. Normal table of postembryonic zebrafish development: Staging by externally visible anatomy of the living fish. Dev. Dyn. 2009 238 12 2975 3015 10.1002/dvdy.22113 19891001
    [Google Scholar]
  13. Dahm R. Zebrafish: A Practical Approach; Nüsslein-Volhard, C. Oxford University PressOxford 2002
    [Google Scholar]
  14. Lawrence C. The husbandry of zebrafish (Danio rerio): A review. Aquaculture 2007 269 1-4 1 20 10.1016/j.aquaculture.2007.04.077
    [Google Scholar]
  15. Hill A.J. Teraoka H. Heideman W. Peterson R.E. Zebrafish as a model vertebrate for investigating chemical toxicity. Toxicol. Sci. 2005 86 1 6 19 10.1093/toxsci/kfi110 15703261
    [Google Scholar]
  16. Fan Y. Jiang C. Li P. Wang C. Chen H. A new chloro-azaphilone derivative with pro-angiogenesis activity from the hadal trench-derived fungus Chaetomium globosum YP-106. J. Oceanol. Limnol. 2023 41 3 1145 1151 10.1007/s00343‑022‑2017‑1
    [Google Scholar]
  17. Li Z. Wu N. Wang J. Yue Y. Geng L. Zhang Q. Low molecular weight fucoidan alleviates cerebrovascular damage by promoting angiogenesis in type 2 diabetes mice. Int. J. Biol. Macromol. 2022 217 345 355 10.1016/j.ijbiomac.2022.07.053 35841956
    [Google Scholar]
  18. Hsu S.Y. Wen Z.H. Shih P.C. Sinularin induces oxidative stress-mediated apoptosis and mitochondrial dysfunction, and inhibits angiogenesis in glioblastoma cells. Antioxidants 2022 11 8 1433 10.3390/antiox11081433 35892635
    [Google Scholar]
  19. Teixeira C.M.M. Correa C.N. Iwai L.K. Ferro E.S. Castro L.M. Characterization of intracellular peptides from zebrafish (Danio rerio) brain. Zebrafish 2019 16 3 240 251 10.1089/zeb.2018.1718 31017557
    [Google Scholar]
  20. Pott A. Shahid M. Köhler D. Therapeutic chemical screen identifies phosphatase inhibitors to reconstitute PKB phosphorylation and cardiac contractility in ILK-deficient zebrafish. Biomolecules 2018 8 4 153 10.3390/biom8040153 30463267
    [Google Scholar]
  21. Raby L. Völkel P. Le Bourhis X. Angrand P.O. Genetic engineering of zebrafish in cancer research. Cancers 2020 12 8 2168 10.3390/cancers12082168 32759814
    [Google Scholar]
  22. Magkos F. Hjorth M.F. Astrup A. Diet and exercise in the prevention and treatment of type 2 diabetes mellitus. Nat. Rev. Endocrinol. 2020 16 10 545 555 10.1038/s41574‑020‑0381‑5 32690918
    [Google Scholar]
  23. Diogo P. Martins G. Simão M. Type I diabetes in zebrafish reduces sperm quality and increases insulin and glucose transporter transcripts. Int. J. Mol. Sci. 2023 24 8 7035 10.3390/ijms24087035 37108202
    [Google Scholar]
  24. Zang L. Shimada Y. Nishimura N. Development of a novel zebrafish model for type 2 diabetes mellitus. Sci. Rep. 2017 7 1 1461 10.1038/s41598‑017‑01432‑w 28469250
    [Google Scholar]
  25. Silva N.G. Preto M. Vasconcelos V. Urbatzka R. Reduction of neutral lipid reservoirs, bioconversion and untargeted metabolomics reveal distinct roles for vitamin K isoforms on lipid metabolism. Food Funct. 2024 15 4 2170 2180 10.1039/D3FO02915H 38312068
    [Google Scholar]
  26. Samarakoon K.W. Kuruppu A.I. Ko J.Y. Lee J.H. Jeon Y.J. Structural characterization and anti-inflammatory effects of 24-Methylcholesta-5(6), 22-Diene-3β-ol from the cultured marine diatom Phaeodactylum tricornutum: Attenuate Inflammatory signaling pathways. Mar. Drugs 2023 21 4 231 10.3390/md21040231 37103370
    [Google Scholar]
  27. Zakaria Z.Z. Benslimane F.M. Nasrallah G.K. Using zebrafish for investigating the molecular mechanisms of drug-induced cardiotoxicity. BioMed Res. Int. 2018 2018 1 10 10.1155/2018/1642684 30363733
    [Google Scholar]
  28. Galicia-Garcia U. Benito-Vicente A. Jebari S. Pathophysiology of type 2 diabetes mellitus. Int. J. Mol. Sci. 2020 21 17 6275 10.3390/ijms21176275 32872570
    [Google Scholar]
  29. Zhang M. Li P. Wang F. Separation, identification and cardiovascular activities of phospholipid classes from the head of Penaeus vannamei by lipidomics and zebrafish models. Food Funct. 2021 12 5 2282 2291 10.1039/D0FO03017A 33599642
    [Google Scholar]
  30. Liao Q. Gong G. Siu S. A novel ShK-Like toxic peptide from the transcriptome of the cnidarian Palythoa caribaeorum displays neuroprotection and cardioprotection in zebrafish. Toxins 2018 10 6 238 10.3390/toxins10060238 29895785
    [Google Scholar]
  31. Miao X. Hong L. Ju Z. Marchaetoglobins A-D: four cytochalasans with proangiogenic activity from the marine-sponge-associated fungus Chaetomium globosum 162105. ACS Omega 2024 9 20 22450 22458 10.1021/acsomega.4c02488 38799354
    [Google Scholar]
  32. Yan L.H. Li P.H. Li X.M. Chevalinulins A and B, proangiogenic alkaloids with a Spiro[bicyclo[2.2.2]octane-diketopiperazine] skeleton from deep-sea cold-seep-derived fungus Aspergillus chevalieri CS-122. Org. Lett. 2022 24 14 2684 2688 10.1021/acs.orglett.2c00781 35389665
    [Google Scholar]
  33. Kim H.S. Kim S.Y. Fernando I.P.S. Free radical scavenging activity of the peptide from the Alcalase hydrolysate of the edible aquacultural seahorse (Hippocampus abdominalis). J. Food Biochem. 2019 43 7 e12833 10.1111/jfbc.12833 31353700
    [Google Scholar]
  34. Wang L. Jayawardena T.U. Yang H.W. Isolation, characterization, and antioxidant activity evaluation of a fucoidan from an enzymatic digest of the edible seaweed, Hizikia fusiforme. Antioxidants 2020 9 5 363 10.3390/antiox9050363 32349336
    [Google Scholar]
  35. Bae H. Lee J.Y. Song J. Song G. Lim W. Osthole interacts with an ER‐mitochondria axis and facilitates tumor suppression in ovarian cancer. J. Cell. Physiol. 2021 236 2 1025 1042 10.1002/jcp.29913 32697363
    [Google Scholar]
  36. Lee J.Y. Bae H. Yang C. Eupatilin promotes cell death by calcium influx through er-mitochondria axis with SERPINB11 inhibition in epithelial ovarian cancer. Cancers 2020 12 6 1459 10.3390/cancers12061459 32503295
    [Google Scholar]
  37. McKeown B.T. Relja N.J. Hall S.R. Pilot study of jadomycin B pharmacokinetics and anti-tumoral effects in zebrafish larvae and mouse breast cancer xenograft models. Can. J. Physiol. Pharmacol. 2022 100 11 1065 1076 10.1139/cjpp‑2022‑0152 35985040
    [Google Scholar]
  38. Wu X.X. Yue G.G.L. Dong J.R. Actein inhibits the proliferation and adhesion of human breast cancer cells and suppresses migration in vivo. Front. Pharmacol. 2018 9 1466 10.3389/fphar.2018.01466 30618758
    [Google Scholar]
  39. King Heiden T.C. Dengler E. Kao W.J. Heideman W. Peterson R.E. Developmental toxicity of low generation PAMAM dendrimers in zebrafish. Toxicol. Appl. Pharmacol. 2007 225 1 70 79 10.1016/j.taap.2007.07.009 17764713
    [Google Scholar]
  40. Bodewein L. Schmelter F. Di Fiore S. Hollert H. Fischer R. Fenske M. Differences in toxicity of anionic and cationic PAMAM and PPI dendrimers in zebrafish embryos and cancer cell lines. Toxicol. Appl. Pharmacol. 2016 305 83 92 10.1016/j.taap.2016.06.008 27288734
    [Google Scholar]
  41. Wu S.Y. Chou H.Y. Tsai H.C. Amino acid-modified PAMAM dendritic nanocarriers as effective chemotherapeutic drug vehicles in cancer treatment: A study using zebrafish as a cancer model. RSC Advances 2020 10 35 20682 20690 10.1039/D0RA01589J 35517745
    [Google Scholar]
  42. Nadar R.A. Asokan N. Degli Esposti L. Preclinical evaluation of platinum-loaded hydroxyapatite nanoparticles in an embryonic zebrafish xenograft model. Nanoscale 2020 12 25 13582 13594 10.1039/D0NR04064A 32555916
    [Google Scholar]
  43. Nagaraj A. Wilson S.A. Vaidyanathan L. Anti-obesity properties of Calocybe indica in zebra fishes with short-term high-fat diet induction. Biomed. Pharmacol. J. 2021 14 1 411 423 10.13005/bpj/2141
    [Google Scholar]
  44. Zhang L.L. Yan Liu D. Ma L.Q. Activation of transient receptor potential vanilloid type-1 channel prevents adipogenesis and obesity. Circ. Res. 2007 100 7 1063 1070 10.1161/01.RES.0000262653.84850.8b 17347480
    [Google Scholar]
  45. Motter A.L. Ahern G.P. TRPV1‐null mice are protected from diet‐induced obesity. FEBS Lett. 2008 582 15 2257 2262 10.1016/j.febslet.2008.05.021 18503767
    [Google Scholar]
  46. Matsumoto T. Miyawaki C. Ue H. Yuasa T. Miyatsuji A. Moritani T. Effects of capsaicin-containing yellow curry sauce on sympathetic nervous system activity and diet-induced thermogenesis in lean and obese young women. J. Nutr. Sci. Vitaminol. (Tokyo) 2000 46 6 309 315 10.3177/jnsv.46.309 11227803
    [Google Scholar]
  47. Ahuja K.D.K. Robertson I.K. Geraghty D.P. Ball M.J. Effects of chili consumption on postprandial glucose, insulin, and energy metabolism. Am. J. Clin. Nutr. 2006 84 1 63 69 10.1093/ajcn/84.1.63 16825682
    [Google Scholar]
  48. Kim Y.J. Choi M.S. Woo J.T. Jeong M.J. Kim S.R. Jung U.J. Long‐term dietary supplementation with low‐dose nobiletin ameliorates hepatic steatosis, insulin resistance, and inflammation without altering fat mass in diet‐induced obesity. Mol. Nutr. Food Res. 2017 61 8 1600889 10.1002/mnfr.201600889 28116779
    [Google Scholar]
  49. Saito T. Abe D. Sekiya K. Nobiletin enhances differentiation and lipolysis of 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun. 2007 357 2 371 376 10.1016/j.bbrc.2007.03.169 17433253
    [Google Scholar]
  50. Rajesh V. Mridhulmohan M. Jayaseelan S. Sivakumar P. Ganesan V. Mefenamic acid attenuates chronic alcohol induced cognitive impairment in zebrafish: Possible role of cholinergic pathway. Neurochem. Res. 2018 43 7 1392 1404 10.1007/s11064‑018‑2554‑3 29796737
    [Google Scholar]
  51. Barbalho P.G. Lopes-Cendes I. Maurer-Morelli C.V. Indomethacin treatment prior to pentylenetetrazole-induced seizures downregulates the expression of il1b and cox2 and decreases seizure-like behavior in zebrafish larvae. BMC Neurosci. 2016 17 1 12 10.1186/s12868‑016‑0246‑y 26961169
    [Google Scholar]
  52. Xia L. Zheng L. Zhou J.L. Effects of ibuprofen, diclofenac and paracetamol on hatch and motor behavior in developing zebrafish (Danio rerio). Chemosphere 2017 182 416 425 10.1016/j.chemosphere.2017.05.054 28511137
    [Google Scholar]
  53. Horie Y. Yamagishi T. Yagi A. Shintaku Y. Iguchi T. Tatarazako N. The non‐steroidal anti‐inflammatory drug diclofenac sodium induces abnormal embryogenesis and delayed lethal effects in early life stage zebrafish (Danio rerio). J. Appl. Toxicol. 2019 39 4 622 629 10.1002/jat.3752 30460707
    [Google Scholar]
  54. Bereketoglu C. Pradhan A. Olsson P.E. Nonsteroidal anti-inflammatory drugs (NSAIDs) cause male-biased sex differentiation in zebrafish. Aquat. Toxicol. 2020 223 105476 10.1016/j.aquatox.2020.105476 32315829
    [Google Scholar]
  55. Hao M. Chu Y. Lei J. Pharmacological mechanisms and clinical applications of curcumin: Update. Aging Dis. 2023 14 3 716 749 10.14336/AD.2022.1101 37191432
    [Google Scholar]
  56. Chen Y. Huang T. Shi W. Fang J. Deng H. Cui G. Potential targets for intervention against doxorubicin-induced cardiotoxicity based on genetic studies: A systematic review of the literature. J. Mol. Cell. Cardiol. 2020 138 88 98 10.1016/j.yjmcc.2019.11.150 31751567
    [Google Scholar]
  57. Pabla N. Dong Z. Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies. Kidney Int. 2008 73 9 994 1007 10.1038/sj.ki.5002786 18272962
    [Google Scholar]
  58. Abbate F. Maugeri A. Laurà R. Zebrafish as a Useful model to study oxidative stress-linked disorders: focus on flavonoids. Antioxidants 2021 10 5 668 10.3390/antiox10050668 33922976
    [Google Scholar]
  59. Meng X. Zhou J. Zhao C.N. Gan R.Y. Li H.B. Health benefits and molecular mechanisms of resveratrol: A narrative review. Foods 2020 9 3 340 10.3390/foods9030340 32183376
    [Google Scholar]
  60. Guo L. Sun J. Wang C. Epirubicin enhances the anti-cancer effects of radioactive 125I Seeds in hepatocellular carcinoma via downregulation of the JAK/STAT1 pathway. Front. Oncol. 2022 12 854023 10.3389/fonc.2022.854023 35692770
    [Google Scholar]
  61. Ayoub S.S. Paracetamol (acetaminophen): A familiar drug with an unexplained mechanism of action. Temperature 2021 8 4 351 371 10.1080/23328940.2021.1886392 34901318
    [Google Scholar]
  62. Fang Z. Zhang M. Liu J. Zhao X. Zhang Y. Fang L. Tanshinone IIA: A review of its anticancer effects. Front. Pharmacol. 2021 11 611087 10.3389/fphar.2020.611087 33597880
    [Google Scholar]
  63. Vane J.R. Botting R.M. The mechanism of action of aspirin. Thromb. Res. 2003 110 5-6 255 258 10.1016/S0049‑3848(03)00379‑7 14592543
    [Google Scholar]
  64. Coutinho A.E. Chapman K.E. The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights. Mol. Cell. Endocrinol. 2011 335 1 2 13 10.1016/j.mce.2010.04.005 20398732
    [Google Scholar]
  65. Kolahdouzan M. Hamadeh M.J. The neuroprotective effects of caffeine in neurodegenerative diseases. CNS Neurosci. Ther. 2017 23 4 272 290 10.1111/cns.12684 28317317
    [Google Scholar]
  66. Wang D.W. Mistry A.M. Kahlig K.M. Kearney J.A. Xiang J. George A.L. Propranolol blocks cardiac and neuronal voltage-gated sodium channels. Front. Pharmacol. 2010 1 144 10.3389/fphar.2010.00144 21833183
    [Google Scholar]
  67. Mauthe M. Orhon I. Rocchi C. Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion. Autophagy 2018 14 8 1435 1455 10.1080/15548627.2018.1474314 29940786
    [Google Scholar]
  68. Ge S. Li J. Tai X. Ginsenoside-enriched extract from black ginseng anti-fatigue effects by improving antioxidant capacity and mitochondrial function. Life 2024 14 11 1467 10.3390/life14111467 39598265
    [Google Scholar]
  69. Kciuk M. Gielecińska A. Mujwar S. Doxorubicin: An agent with multiple mechanisms of anticancer activity. Cells 2023 12 4 659 10.3390/cells12040659 36831326
    [Google Scholar]
  70. Wang Y. Liu Y. Du X. Ma H. Yao J. The anti-cancer mechanisms of berberine: A review. Cancer Manag. Res. 2020 12 695 702 10.2147/CMAR.S242329 32099466
    [Google Scholar]
  71. Hasan A.A. Tatarskiy V. Kalinina E. Synthetic pathways and the therapeutic potential of quercetin and curcumin. Int. J. Mol. Sci. 2022 23 22 14413 10.3390/ijms232214413 36430891
    [Google Scholar]
  72. Mohammadzadeh N. Mehri S. Hosseinzadeh H. Berberis vulgaris and its constituent berberine as antidotes and protective agents against natural or chemical toxicities. Iran. J. Basic Med. Sci. 2017 20 5 538 551 10.22038/IJBMS.2017.8678 28656089
    [Google Scholar]
  73. Singh S.K. Srivastav S. Castellani R.J. Plascencia-Villa G. Perry G. Neuroprotective and antioxidant effect of Ginkgo biloba extract against AD and other neurological disorders. Neurotherapeutics 2019 16 3 666 674 10.1007/s13311‑019‑00767‑8 31376068
    [Google Scholar]
  74. Wylie M.R. Merrell D.S. The Antimicrobial Potential of the Neem Tree Azadirachta indica. Front. Pharmacol. 2022 13 891535 10.3389/fphar.2022.891535 35712721
    [Google Scholar]
  75. Hekmatpou D. Mehrabi F. Rahzani K. Aminiyan A. The effect of aloe vera clinical trials on prevention and healing of skin wound: A systematic review. Iran. J. Med. Sci. 2019 44 1 1 9 [PMID: 30666070
    [Google Scholar]
  76. Singh S. Majumdar D.K. Rehan H.M.S. Evaluation of anti-inflammatory potential of fixed oil of Ocimum sanctum (Holybasil) and its possible mechanism of action. J. Ethnopharmacol. 1996 54 1 19 26 10.1016/0378‑8741(96)83992‑4 8941864
    [Google Scholar]
  77. Guo S. Rezaei M.J. The benefits of ashwagandha (Withania somnifera) supplements on brain function and sports performance. Front. Nutr. 2024 11 1439294 10.3389/fnut.2024.1439294 39155932
    [Google Scholar]
  78. Mikulska P. Malinowska M. Ignacyk M. Ashwagandha (Withania somnifera)—Current research on the health-promoting activities: A narrative review. Pharmaceutics 2023 15 4 1057 10.3390/pharmaceutics15041057 37111543
    [Google Scholar]
  79. Chablais F. Veit J. Rainer G. Jaźwińska A. The zebrafish heart regenerates after cryoinjury-induced myocardial infarction. BMC Dev. Biol. 2011 11 1 21 10.1186/1471‑213X‑11‑21 21473762
    [Google Scholar]
  80. Horzmann K. Freeman J. Zebrafish get connected: Investigating neurotransmission targets and alterations in chemical toxicity. Toxics 2016 4 3 19 10.3390/toxics4030019 28730152
    [Google Scholar]
  81. Irie N. Kuratani S. Comparative transcriptome analysis reveals vertebrate phylotypic period during organogenesis. Nat. Commun. 2011 2 1 248 10.1038/ncomms1248 21427719
    [Google Scholar]
  82. Kalinka A.T. Varga K.M. Gerrard D.T. Gene expression divergence recapitulates the developmental hourglass model. Nature 2010 468 7325 811 814 10.1038/nature09634 21150996
    [Google Scholar]
  83. Kalueff A.V. Gebhardt M. Stewart A.M. Towards a comprehensive catalog of zebrafish behavior 1.0 and beyond. Zebrafish 2013 10 1 70 86 10.1089/zeb.2012.0861 23590400
    [Google Scholar]
  84. Pfeiffer B.E. Foster D.J. Hippocampal place-cell sequences depict future paths to remembered goals. Nature 2013 497 7447 74 79 10.1038/nature12112 23594744
    [Google Scholar]
  85. Kokel D. Bryan J. Laggner C. Rapid behavior-based identification of neuroactive small molecules in the zebrafish. Nat. Chem. Biol. 2010 6 3 231 237 10.1038/nchembio.307 20081854
    [Google Scholar]
  86. Gonzales J.M. Law S.H.W. Feed and feeding regime affect growth rate and gonadosomatic index of adult zebrafish (Danio rerio). Zebrafish 2013 10 4 532 540 10.1089/zeb.2013.0891 23902461
    [Google Scholar]
  87. Miron V.E. Kuhlmann T. Antel J.P. Cells of the oligodendroglial lineage, myelination, and remyelination. Biochim. Biophys. Acta Mol. Basis Dis. 2011 1812 2 184 193 10.1016/j.bbadis.2010.09.010 20887785
    [Google Scholar]
  88. Poss K.D. Wilson L.G. Keating M.T. Heart regeneration in zebrafish. Science 2002 298 5601 2188 2190 10.1126/science.1077857 12481136
    [Google Scholar]
  89. Lawrence C. Sanders G.E. Varga Z.M. Regulatory compliance and the zebrafish. Zebrafish 2009 6 4 453 456 10.1089/zeb.2009.0595 19916799
    [Google Scholar]
  90. Schmidt R. Strähle U. Scholpp S. Neurogenesis in zebrafish - from embryo to adult. Neural Dev. 2013 8 1 3 10.1186/1749‑8104‑8‑3 23433260
    [Google Scholar]
  91. Stewart A. Wong K. Cachat J. Zebrafish models to study drug abuse-related phenotypes. Rev. Neurosci. 2011 22 95 105 10.1515/rns.2011.011
    [Google Scholar]
  92. Aleström P. D’Angelo L. Midtlyng P.J. Zebrafish: Housing and husbandry recommendations. Lab. Anim. 2020 54 3 213 224 10.1177/0023677219869037 31510859
    [Google Scholar]
  93. Chen A.C. Welsh R.C. Liberzon I. Taylor S.F. ‘Do I like this person?’ A network analysis of midline cortex during a social preference task. Neuroimage 2010 51 2 930 939 10.1016/j.neuroimage.2010.02.044 20188190
    [Google Scholar]
  94. Lee G. Chung J. Discrete functions of rictor and raptor in cell growth regulation in Drosophila. Biochem. Biophys. Res. Commun. 2007 357 4 1154 1159 10.1016/j.bbrc.2007.04.086 17462592
    [Google Scholar]
/content/journals/cpd/10.2174/0113816128396857250917224145
Loading
Current Role of the Zebrafish Experimental Model in Pharmacological Evaluations of Drugs: Current and Future Perspectives
Bentham Science Publishers ; https://doi.org/10.2174/0113816128396857250917224145
/content/journals/cpd/10.2174/0113816128396857250917224145
/content/journals/cpd/10.2174/0113816128396857250917224145
Loading

Data & Media loading...

Supplements

PRISMA checklist is available as supplementary material on the publisher’s website along with the published article.

file format download Download

  • Article Type:     Review Article
Keywords: High-throughput screening ; biomedical research ; drug discovery ; toxicity assessment ; blastula stage ; Zebrafish (Danio rerio)

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test